IN8bio, Inc. (INAB)
1.64
+0.06
(+3.80%)
USD |
NASDAQ |
May 11, 14:50
IN8bio Total Liabilities (Quarterly) : 3.484M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| DiaMedica Therapeutics, Inc. | 5.845M |
| Calidi Biotherapeutics, Inc. | 5.098M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Amgen, Inc. | 83.31B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.26M |
| Shareholders Equity (Quarterly) | 22.78M |
| Debt to Equity Ratio | 0.1033 |
| Current Ratio | 10.50 |
| Net Debt Paydown Yield | 7.97% |